Literature DB >> 19826096

Evaluation of compliance with osteoporosis treatment guidelines after initiation of a pharmacist-run osteoporosis service at a family medicine clinic.

Larissa N Hall1, Sarah P Shrader, Kelly R Ragucci.   

Abstract

BACKGROUND: Osteoporosis affects more than 10 million Americans, and fracture complications are devastating to patients and society. Despite the availability of guidelines and performance measures, osteoporosis is not optimally managed. Pharmacists have been pivotal in management of other disease states, and a multidisciplinary approach to osteoporosis management may improve patient outcomes.
OBJECTIVE: To establish a pharmacist-run osteoporosis service at a family medicine clinic and to evaluate short-term compliance with osteoporosis treatment guidelines before and after initiation of the service.
METHODS: A pharmacist-run osteoporosis service was established in October 2008. Adults with the diagnosis of osteoporosis before initiation of the service were included in evaluation of short-term compliance with treatment guidelines, including appropriate dual-energy X-ray absorptiometry (DEXA) scan frequency, pharmacotherapy, calcium and vitamin D supplementation, and nonpharmacologic education. Of 42 referred patients, 22 were eligible for inclusion. A retrospective chart review was conducted, and patients served as their own controls, with data from before and after establishment of the service evaluated.
RESULTS: Of the 22 patients evaluated, 8 (36%) received DEXA scans at the appropriate frequency before the service was established, versus 18 (82%) after the service was initiated. Seven (32%) patients were taking appropriate pharmacotherapy before the service, versus 17 (77%) after the service. Nine (41%) patients were taking calcium and vitamin D before the service, versus 22 (100%) after the service. Three (33%) of these patients were taking the appropriate dose and salt of calcium before the service, versus 20 (91%) after the service. Five (56%) of the 9 patients were taking the appropriate vitamin D dose before the service, versus 21 (95%) after the service. No patient had documented nonpharmacologic education prior to the service, compared with all patients after the service. All differences were significant (p < 0.05).
CONCLUSIONS: A pharmacist-run osteoporosis service significantly improved short-term compliance with guidelines, including appropriate DEXA scan frequency, pharmacotherapy, calcium and vitamin D supplementation, and nonpharmacologic education.

Entities:  

Mesh:

Year:  2009        PMID: 19826096     DOI: 10.1345/aph.1M366

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  4 in total

1.  Assessment of the presence and quality of osteoporosis prevention education among at-risk internal medicine patients.

Authors:  Jennifer A Shulha; Cortney B Sviggum; John G O'Meara; Melody L Berg
Journal:  Consult Pharm       Date:  2014-01

2.  Improving osteoporosis management in general practice: a pharmacist-led drug use evaluation program.

Authors:  Edwin C K Tan; Johnson George; Kay Stewart; Rohan A Elliott
Journal:  Drugs Aging       Date:  2014-09       Impact factor: 3.923

3.  Quality of care provided to prostate cancer (PC) patients for prevention and treatment of osteoporosis induced by androgen deprivation therapy (ADT).

Authors:  Rehab Chahin; Husayn Gulamhusein; Henriette Breunis; Shabbir M H Alibhai
Journal:  Support Care Cancer       Date:  2016-07-02       Impact factor: 3.603

Review 4.  The impact of pharmacist interventions on osteoporosis management: a systematic review.

Authors:  M N Elias; A M Burden; S M Cadarette
Journal:  Osteoporos Int       Date:  2011-07-01       Impact factor: 4.507

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.